Literature DB >> 33881743

Post-COVID Syndrome (MIS-C) with Refractory Status Epilepticus.

Haripal Kashyap1, Vineetranjan Gupta2, Arvind Gupta1, Tarun Gupta1, Seshendra Sharma1, Shreyansh Valjiyani1.   

Abstract

Entities:  

Year:  2021        PMID： 33881743     DOI： 10.1007/s12098-021-03731-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  2 in total

Review 1.  Post COVID-19 neurological complications; a meta-analysis.

Authors:  Jaafar Omer Ahmed; Shwan Abdubakr Ahmad; Marwan Nasih Hassan; Fahmi H Kakamad; Rawezh Q Salih; Berwn A Abdulla; Fattah Hama Rahim Fattah; Shvan H Mohammed; Razhan K Ali; Abdulwahid M Salih
Journal:  Ann Med Surg (Lond)       Date:  2022-03-03

2.  Treatment of COVID-19-induced refractory status epilepticus by tocilizumab.

Authors:  Esra Kochan Kizilkilic; Rumeysa Unkun; Ugur Uygunoglu; Sakir Delil; Cigdem Ozkara
Journal:  Eur J Neurol       Date:  2022-06-22       Impact factor: 6.288
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.